SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-032332
Filing Date
2021-03-04
Accepted
2021-03-04 21:30:34
Documents
1
Period of Report
2021-03-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm218800d1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm218800d1_3seq1.xml 3 1595
  Complete submission text file 0001104659-21-032332.txt   3149
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Issuer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 900 NORTHBROOK DRIVE SUITE 200 TREVOSE PA 19053
Business Address
Lutz Robert Matthew (Reporting) CIK: 0001786203 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35023 | Film No.: 21716285